GSK News — every source, one live feed
Track GSK news in real time — British pharma group centered on vaccines, HIV treatments, and specialty medicines.. fllwup^ collects the latest GSK headlines from every major source into one live feed — free, no account, no algorithm. Coverage aggregated from BBC, Reuters, AP, NYT, TechCrunch, Al Jazeera, and 200+ other outlets.
Latest GSK headlines
- A Look at GSK PLC (GSK) After 3.4% Gain -- GF Value $45.43 vs Pr — GuruFocus
- GSK secures preclinical dengue antibody from Chugai — AllSci
- GSK (LON:GSK) Earns Hold Rating from Deutsche Bank Aktiengesellschaft — MarketBeat
- GSK Set up for Steady Long-Term Growth As Portfolio and Pipeline Develop — Morningstar
- GSK Eyes AnaptysBio (ANAB) Acquisition to Secure Drug Control — Yahoo Finance
- GSK lays out plans to cut costs, pursue more late-stage drug trials — STAT
- GSK takes full rights to Chugai's experimental anti-dengue virus antibody — FirstWord Pharma
- M&A Roundup: LEO Pharma Acquires Dersimelagon, BioMarin Acquires Alesta, OmniAb Enters collaboration with Eli Lilly, Chugai and GSK Enter License Agreement for AID351 — Pharmaceutical Executive
- GSK to establish new flagship R&D centre on Cambridge Biomedical Campus, UK — GSK
- GSK raises margin outlook, plots $2.5 billion restructuring to fast-track new drugs — Reuters
Follow GSK live on fllwup^ — or browse all topics.
More Global Stocks & ADRs: browse the category. Compare: fllwup^ vs Flipboard · vs Feedly · vs Google News · vs Apple News.